A5030785133- Systemic Lupus Erythematosus Research
- Platelet Disorders and Treatments
- Systemic Sclerosis and Related Diseases
- Heparin-Induced Thrombocytopenia and Thrombosis
- Drug-Induced Ocular Toxicity
- Ocular Diseases and Behçet’s Syndrome
- Renal Diseases and Glomerulopathies
- Blood Coagulation and Thrombosis Mechanisms
- Autoimmune and Inflammatory Disorders Research
- Rheumatoid Arthritis Research and Therapies
- Venous Thromboembolism Diagnosis and Management
- Parvovirus B19 Infection Studies
- Retinal and Optic Conditions
- Blood disorders and treatments
- Peripheral Neuropathies and Disorders
- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Bone and Joint Diseases
- Pituitary Gland Disorders and Treatments
- Muscle and Compartmental Disorders
- Adrenal Hormones and Disorders
- COVID-19 and healthcare impacts
- Inflammasome and immune disorders
- Kawasaki Disease and Coronary Complications
- COVID-19 Clinical Research Studies
Hospital Federal dos Servidores do Estado
2013-2023
Johns Hopkins University
2006-2009
Johns Hopkins Medicine
2006-2009
Objective. Antiphospholipid syndrome (APS) is characterized by thrombosis (venous and arterial) pregnancy loss in conjunction with the lupus anticoagulant, IgG or IgM anticardiolipin, anti-ß 2 -glycoprotein I. In most series, only a minority of patients antiphospholipid antibodies develop clinical manifestation. Methods. A cross-sectional study consecutive Hopkins Lupus Center was performed. Interviews were done records reviewed for following variables: gender, ethnicity, hypertension,...
A síndrome do anticorpo antifosfolipídeo (SAF) é uma doença sistêmica autoimune caracterizada por trombose arterial e venosa, morbidade gestacional presença de níveis séricos anticorpos antifosfolipídeos elevados persistentemente positivos. O tratamento da SAF ainda sujeito a controvérsias, já que qualquer decisão terapêutica potencialmente irá confrontar-se com o risco cobertura antitrombótica insuficiente ou excessivo associado à anticoagulação seus principais efeitos adversos. Esta...
The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by arterial and venous thrombosis, gestational morbidity presence of elevated persistently positive serum titers antibodies. treatment APS still controversial, because any therapeutic decision potentially faces the risk an insufficient or excessive antithrombotic coverage associated with anticoagulation its major adverse effects. This guideline was elaborated from nine relevant clinical questions related to...
Antimalarials are key drugs in systemic lupus erythematosus (SLE) and related diseases.Retinal toxicity remains the most worrisome complication.The present work aims to determine prevalence of retinopathy hydroxychloroquine (HCQ) users risk factors potentially associated with retinal HCQ toxicity.